Skip to content

Clinical trials

Terminated Phase 2 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 2 Status: Terminated Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20103
20111
20121
20131
20151
20162
20171
20183
20195
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Aires Pharmaceuticals, Inc.2
Complexa, Inc.2
Idorsia Pharmaceuticals Ltd.2
PhaseBio Pharmaceuticals Inc.2
Actelion1
Altavant Sciences GmbH1
Boston University1
Eiger BioPharmaceuticals1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension26
Hypertension, Pulmonary14
Connective Tissue Diseases3
Familial Primary Pulmonary Hypertension3
Cardiovascular Diseases2
Cough2
Dizziness2
Dyspnea2
Hypertension2
Lung Diseases2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.